Chemical Company of Malaysia Berhad announced that Duopharma Biotech Berhad (DBB) (previously known as CCM Duopharma Biotech Berhad) had on 29 November 2019, exercised its Option to Renew the Trademarks License Agreement (TLA) in accordance to the terms and conditions of the TLA for a further period of 1 year commencing on 1 January 2020. The said renewal is on the same terms and conditions of the TLA.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 MYR | -0.78% | +4.10% | +0.79% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.79% | 259M | |
+19.64% | 43.03B | |
+23.86% | 22.7B | |
+17.29% | 15.07B | |
+23.64% | 14.77B | |
+59.16% | 13.05B | |
-0.05% | 6.79B | |
-14.19% | 6.58B | |
-8.87% | 5.73B | |
+13.42% | 5.5B |
- Stock Market
- Equities
- DPHARMA Stock
- News Duopharma Biotech
- Chemical Company of Malaysia Berhad Renews Trademarks License Agreement with Duopharma Biotech Berhad